Vessi’s bladder-specific cryoablation technology may eliminate problems often reported with transurethral resection of bladder tumor (TURBT), today’s first line of treatment.
… Welcome 3 new medical portfolio companies … ViAqua closes investment round … ZygoFix receives Horizon 2020 grant … CoreBone wins in China …
Trendlines new Singapore-based venture fund has been appointed as one of the partners under the SEEDS Capital Startup SG Equity scheme.
Leviticus Cardio and Jarvik Heart were awarded an R&D grant from the prestigious Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.
We plan to raise a $40 million venture fund to support the center’s investment activity.
AgFunder featured exclusive coverage of ViAqua’s investment from Singapore-based VisVires New Protein.
… Marking 3 years on the Singapore Exchange … Welcome 3 new companies … ZygoFix starts FIH … Leviticus achieves significant preclinical milestone … Saturas enters new market …
The procedures in Singapore with the ApiFix system “went exceptionally well and significant curve correction was achieved … .”
ZygoFix announced the successful start of a first in human clinical study for its zLOCK spinal facet joint fixation system.
IntraFish featured BioFishency’s “plug-and-play filter system” for aquaculture.